NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 810.20
-13.50 (-1.64%)
At close: Oct 7, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 145.1 billion as of October 7, 2026. Its market cap has decreased by 0.62% in one year.
Market Cap
145.10B
Enterprise Value
130.94B
Revenue
34.85B
Global Rank
n/a
Country Rank
n/a
PE Ratio
12.68
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 145.10B, an increase of 33,691.52%. That is a compound annual growth rate of 23.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 145.10B | -10.29% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |
| Jubilant Pharmova | 158.49B |
| AstraZeneca Pharma India | 150.76B |
| Viyash Scientific | 101.17B |
| Procter & Gamble Health | 89.04B |
| Morepen Laboratories | 73.26B |